Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers
- Author
- TAKADA, Toshio1 2 ; YAGI, Yukiko1 ; USHIJIMA, Toshikazu1 ; MAEKITA, Takao1 ; IMURA, Masayoshi1 2 ; NAKAGAWA, Shunsuke2 ; TSAO, Sai-Wah3 ; MIYAMOTO, Kazuaki1 ; YOSHINO, Osamu2 ; YASUGI, Toshiharu2 ; TAKETANI, Yuji2
[1] Carcinogenesis Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
[2] Department of Obstetrics and Gynecology, Graduate School of Medicine, University of Tokyo 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
[3] Department of Anatomy, Faculty of Medicine, University of Hong Kong, Hong-Kong - Source
Cancer science. 2004, Vol 95, Num 9, pp 741-744, 4 p ; ref : 27 ref
- ISSN
- 1347-9032
- Scientific domain
- Medical oncology
- Publisher
- Blackwell, Tokyo
- Publication country
- Japan
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antagoniste Cancérologie Génétique Homme Méthylation Silence expression génique Tumeur maligne Cancer de l'ovaire Gène wnt Appareil génital femelle pathologie Ovaire pathologie
- Keyword (en)
- Antagonist Cancerology Genetics Human Methylation Gene silencing Malignant tumor Ovary cancer Female genital diseases Ovarian diseases
- Keyword (es)
- Antagonista Cancerología Genética Hombre Metilación Silencio expresión genética Tumor maligno Cáncer del ovario Aparato genital hembra patología Ovario patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20C Female genital diseases / 002B20C02 Tumors
- Discipline
- Gynecology. Andrology. Obstetrics Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 16227575
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.1349-7006.2004.tb03255.x 
https://dx.doi.org/10.1111/j.1349-7006.2004.tb03255.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1349-7006.2004.tb03255.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers\";s:9:\"\u0000*\u0000jtitle\";s:14:\"Cancer science\";s:9:\"\u0000*\u0000stitle\";s:10:\"Cancer sci\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"95\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:3:\"741\";s:8:\"\u0000*\u0000epage\";s:3:\"744\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1347-9032\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"TAKADA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Toshio\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:12:\"YAGI, Yukiko\";i:1;s:19:\"USHIJIMA, Toshikazu\";i:2;s:14:\"MAEKITA, Takao\";i:3;s:16:\"IMURA, Masayoshi\";i:4;s:18:\"NAKAGAWA, Shunsuke\";i:5;s:13:\"TSAO, Sai-Wah\";i:6;s:17:\"MIYAMOTO, Kazuaki\";i:7;s:14:\"YOSHINO, Osamu\";i:8;s:17:\"YASUGI, Toshiharu\";i:9;s:14:\"TAKETANI, Yuji\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:90:\"Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers\";s:8:\"\u0000*\u0000place\";s:5:\"Tokyo\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1349-7006.2004.tb03255.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers\";s:9:\"\u0000*\u0000jtitle\";s:14:\"Cancer science\";s:9:\"\u0000*\u0000stitle\";s:10:\"Cancer sci\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"95\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:3:\"741\";s:8:\"\u0000*\u0000epage\";s:3:\"744\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1347-9032\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"TAKADA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Toshio\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:12:\"YAGI, Yukiko\";i:1;s:19:\"USHIJIMA, Toshikazu\";i:2;s:14:\"MAEKITA, Takao\";i:3;s:16:\"IMURA, Masayoshi\";i:4;s:18:\"NAKAGAWA, Shunsuke\";i:5;s:13:\"TSAO, Sai-Wah\";i:6;s:17:\"MIYAMOTO, Kazuaki\";i:7;s:14:\"YOSHINO, Osamu\";i:8;s:17:\"YASUGI, Toshiharu\";i:9;s:14:\"TAKETANI, Yuji\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:90:\"Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers\";s:8:\"\u0000*\u0000place\";s:5:\"Tokyo\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1349-7006.2004.tb03255.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1349-7006.2004.tb03255.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers\";s:9:\"\u0000*\u0000jtitle\";s:14:\"Cancer science\";s:9:\"\u0000*\u0000stitle\";s:10:\"Cancer sci\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"95\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:3:\"741\";s:8:\"\u0000*\u0000epage\";s:3:\"744\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1347-9032\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"TAKADA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Toshio\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:12:\"YAGI, Yukiko\";i:1;s:19:\"USHIJIMA, Toshikazu\";i:2;s:14:\"MAEKITA, Takao\";i:3;s:16:\"IMURA, Masayoshi\";i:4;s:18:\"NAKAGAWA, Shunsuke\";i:5;s:13:\"TSAO, Sai-Wah\";i:6;s:17:\"MIYAMOTO, Kazuaki\";i:7;s:14:\"YOSHINO, Osamu\";i:8;s:17:\"YASUGI, Toshiharu\";i:9;s:14:\"TAKETANI, Yuji\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:90:\"Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers\";s:8:\"\u0000*\u0000place\";s:5:\"Tokyo\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1349-7006.2004.tb03255.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers\";s:9:\"\u0000*\u0000jtitle\";s:14:\"Cancer science\";s:9:\"\u0000*\u0000stitle\";s:10:\"Cancer sci\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"95\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:3:\"741\";s:8:\"\u0000*\u0000epage\";s:3:\"744\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1347-9032\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"TAKADA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Toshio\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:12:\"YAGI, Yukiko\";i:1;s:19:\"USHIJIMA, Toshikazu\";i:2;s:14:\"MAEKITA, Takao\";i:3;s:16:\"IMURA, Masayoshi\";i:4;s:18:\"NAKAGAWA, Shunsuke\";i:5;s:13:\"TSAO, Sai-Wah\";i:6;s:17:\"MIYAMOTO, Kazuaki\";i:7;s:14:\"YOSHINO, Osamu\";i:8;s:17:\"YASUGI, Toshiharu\";i:9;s:14:\"TAKETANI, Yuji\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:90:\"Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers\";s:8:\"\u0000*\u0000place\";s:5:\"Tokyo\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1349-7006.2004.tb03255.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers\";s:9:\"\u0000*\u0000jtitle\";s:14:\"Cancer science\";s:9:\"\u0000*\u0000stitle\";s:10:\"Cancer sci\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"95\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:3:\"741\";s:8:\"\u0000*\u0000epage\";s:3:\"744\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1347-9032\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"TAKADA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Toshio\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:12:\"YAGI, Yukiko\";i:1;s:19:\"USHIJIMA, Toshikazu\";i:2;s:14:\"MAEKITA, Takao\";i:3;s:16:\"IMURA, Masayoshi\";i:4;s:18:\"NAKAGAWA, Shunsuke\";i:5;s:13:\"TSAO, Sai-Wah\";i:6;s:17:\"MIYAMOTO, Kazuaki\";i:7;s:14:\"YOSHINO, Osamu\";i:8;s:17:\"YASUGI, Toshiharu\";i:9;s:14:\"TAKETANI, Yuji\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:90:\"Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers\";s:8:\"\u0000*\u0000place\";s:5:\"Tokyo\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
